Adaptive Biotechnologies ADPT
NASDAQ ADPT
$26.42 +0.26 (+0.99%)
As of: Aug 27, 2026 · 3:59 PM EDT

Adaptive Biotechnologies (ADPT) Non Operating Interest Expenses (2022 - 2026)

Adaptive Biotechnologies (ADPT) Non Operating Interest Expenses (2022 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Interest Expenses (Qtr)
1 Thermo Fisher Scientific 234.15 Bn 230.09 Bn 8.34 Bn 401.00 Mn
2 Danaher 152.10 Bn 147.75 Bn 3.61 Bn 107.00 Mn
3 Natera 48.48 Bn 47.38 Bn 486.15 Mn 890,000.00
4 Agilent Technologies 44.35 Bn 42.55 Bn 990.00 Mn 25.00 Mn
5 Iqvia Holdings 43.68 Bn 41.60 Bn 1.44 Bn 197.00 Mn
6 Idexx Laboratories 43.02 Bn 42.83 Bn 779.09 Mn 10.18 Mn
7 Illumina 34.39 Bn 33.22 Bn 770.00 Mn 24.00 Mn
8 Mettler Toledo International 28.29 Bn 28.24 Bn 650.22 Mn 17.25 Mn
9 Labcorp Holdings 27.51 Bn 27.37 Bn 1.11 Bn 61.10 Mn
10 Adaptive Biotechnologies 4.23 Bn 3.89 Bn 51.39 Mn 2.69 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 2.69 Mn
Mar 31, 2026 2.89 Mn
Dec 31, 2025 2.95 Mn
Sep 30, 2025 2.97 Mn
Jun 30, 2025 2.95 Mn
Mar 31, 2025 2.91 Mn
Dec 31, 2024 2.95 Mn
Sep 30, 2024 2.94 Mn
Jun 30, 2024 2.70 Mn
Mar 31, 2024 2.99 Mn
Dec 31, 2023 3.01 Mn
Sep 30, 2023 3.65 Mn
Jun 30, 2023 3.61 Mn
Mar 31, 2023 3.53 Mn
Dec 31, 2022 3.59 Mn
Sep 30, 2022 653,000.00